MarketInOut Stock Screener Log In | Sign Up
 

Medpace Holdings Inc

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 09/10/2026 15:29
Medpace Holdings Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization16,516 mln
Float22.37 mln
Earnings Date10/26/2026

EPS

17.03
Robust

P / E

34.25
Overvalued

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.89
Likely reliable

1-Year Forecast

582
Fairly priced

Relative Strength

25 / 100
Underperforming

Business Description

Founded in 1992 and headquartered in Cincinnati, Ohio, Medpace Holdings helps pharmaceutical, biotechnology, and medical device companies bring new treatments to market. The company manages the full range of clinical trial stages across more than six continents, handling everything from study design and regulatory submissions to laboratory testing, data analysis, and patient safety monitoring. Medpace also provides specialized support services including human pharmacology studies, medical imaging, and heart monitoring for clinical trials.

Key Fundamentals

EPS17.03
P/E34.25
ROE126
RPS98.47
ROIC24.12
ROA25.90
EBITDA, mln611
EV / EBITDA26.80
EV / EBIT28.08
Revenue, mln2,782
EV / Revenue5.89

Financial Strength

Altman Z-Score7.94
Piotroski F-Score 8 / 9
Beneish M-Score-2.89
Price to Intrinsic Value2.53
Price to Lynch Fair Value1.41
1-Year Target Price582
Shiller PE Ratio80.88
Short Ratio4.61
Short % of Float7.06

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.8% 36 / 100   
1 Month -3.83% 36 / 100   
2 Months 29.17% 93 / 100   
6 Months 21.9% 83 / 100   
1 Year 19.92% 73 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us